JP2012500184A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500184A5
JP2012500184A5 JP2011507735A JP2011507735A JP2012500184A5 JP 2012500184 A5 JP2012500184 A5 JP 2012500184A5 JP 2011507735 A JP2011507735 A JP 2011507735A JP 2011507735 A JP2011507735 A JP 2011507735A JP 2012500184 A5 JP2012500184 A5 JP 2012500184A5
Authority
JP
Japan
Prior art keywords
amino acid
antigen
peptide
hla
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011507735A
Other languages
English (en)
Japanese (ja)
Other versions
JP5633025B2 (ja
JP2012500184A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2009/003897 external-priority patent/WO2010021112A1/en
Publication of JP2012500184A publication Critical patent/JP2012500184A/ja
Publication of JP2012500184A5 publication Critical patent/JP2012500184A5/ja
Application granted granted Critical
Publication of JP5633025B2 publication Critical patent/JP5633025B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011507735A 2008-08-19 2009-08-14 Hig2およびurlc10エピトープペプチドならびにそれを含むワクチン Active JP5633025B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8997208P 2008-08-19 2008-08-19
US61/089,972 2008-08-19
PCT/JP2009/003897 WO2010021112A1 (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same

Publications (3)

Publication Number Publication Date
JP2012500184A JP2012500184A (ja) 2012-01-05
JP2012500184A5 true JP2012500184A5 (https=) 2012-09-27
JP5633025B2 JP5633025B2 (ja) 2014-12-03

Family

ID=41707003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011507735A Active JP5633025B2 (ja) 2008-08-19 2009-08-14 Hig2およびurlc10エピトープペプチドならびにそれを含むワクチン

Country Status (16)

Country Link
US (1) US9119800B2 (https=)
EP (1) EP2328600B9 (https=)
JP (1) JP5633025B2 (https=)
KR (1) KR101713581B1 (https=)
CN (2) CN102186491B (https=)
AU (1) AU2009283763B2 (https=)
BR (1) BRPI0917391A2 (https=)
CA (1) CA2734467C (https=)
DK (1) DK2328600T3 (https=)
ES (1) ES2566011T3 (https=)
IL (1) IL211117A (https=)
MX (2) MX337756B (https=)
RU (1) RU2529373C2 (https=)
SG (2) SG193806A1 (https=)
TW (2) TWI580431B (https=)
WO (1) WO2010021112A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
SMT201800444T1 (it) * 2010-11-17 2018-09-13 Aduro Biotech Inc Metodi e composizioni per indurre una risposta immunitaria contro egfrviii
WO2014010232A1 (en) 2012-07-10 2014-01-16 Oncotherapy Science, Inc. Ly6k epitope peptides for th1 cells and vaccines containing the same
SG11201700838VA (en) 2014-08-04 2017-03-30 Oncotherapy Science Inc Urlc10-derived peptide and vaccine containing same
AU2016306408B2 (en) 2015-08-10 2021-02-11 Toray Industries, Inc. Immune inducer
CA2994929A1 (en) 2015-08-12 2017-02-16 Oncotherapy Science, Inc. Depdc1-derived peptide and vaccine containing same
JP7538601B2 (ja) 2017-04-26 2024-08-22 ユーリカ セラピューティックス, インコーポレイテッド キメラ活性化受容体及びキメラ刺激受容体を発現する細胞並びにその使用
BR112019027133B8 (pt) 2017-06-20 2022-08-09 Inst Curie Uso de uma célula imune modificada deficiente para suv39h1
CN115300609A (zh) * 2021-05-08 2022-11-08 西湖大学 缺氧诱导脂滴相关蛋白(hilpda)在预防或治疗高血脂相关疾病中的应用
CN120842356A (zh) * 2025-07-25 2025-10-28 广西医科大学附属肿瘤医院 Ly6k抗原表位肽、组合物及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070014787A1 (en) 1998-07-15 2007-01-18 Human Genome Sciences, Inc. 71 human secreted proteins
EP1207199B1 (en) 1999-08-05 2010-04-14 Green Peptide Co., Ltd. Tumor antigen
WO2001023426A2 (en) 1999-09-30 2001-04-05 Varian Associates, Inc. Hypoxia-related human genes, proteins, and uses thereof
EP1474528A4 (en) 2000-10-13 2006-06-14 Protein Design Labs Inc METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF EXAMINING PROSTATE CANCER MODULATORS
US20030232350A1 (en) 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20070015271A1 (en) 2002-04-04 2007-01-18 Rosen Craig A Human secreted proteins
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
JP4614952B2 (ja) 2003-08-20 2011-01-19 オンコセラピー・サイエンス株式会社 腎細胞癌(rcc)の潜在的な新規治療標的としての低酸素誘導タンパク質2(hig2)
CA2570392A1 (en) 2004-06-21 2005-12-29 Green Peptide Co., Ltd. Peptide vaccine for cancer therapy
CN101175862A (zh) 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
ES2364670T3 (es) * 2005-02-25 2011-09-12 Oncotherapy Science, Inc. Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos ttk.
CA2599875A1 (en) 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited Preventive/therapeutic agent for cancer
WO2007013575A2 (en) 2005-07-28 2007-02-01 Oncotherapy Science, Inc. Method for diagnosing and treating renal cell carcinoma
US20080306243A1 (en) 2005-09-07 2008-12-11 Nec Corporation Hla-Binding Peptide, and Dna Fragment and Recombinant Vector Coding for Said Hla-Binding Peptide
JP4840858B2 (ja) 2006-03-16 2011-12-21 学校法人慶應義塾 癌ワクチン
AU2007259667B2 (en) * 2006-06-16 2012-06-14 Oncotherapy Science, Inc. SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
WO2009016691A1 (en) 2007-07-30 2009-02-05 Oncotherapy Science, Inc. Cancer associated gene ly6k
TW201000115A (en) 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Similar Documents

Publication Publication Date Title
JP2012500184A5 (https=)
JP7687767B2 (ja) 呼吸器合胞体ウイルスワクチン
Liu et al. Engineering neoantigen vaccines to improve cancer personalized immunotherapy
JP2012500001A5 (https=)
AU2016264623B2 (en) Shared neoantigens
JP2010519176A5 (https=)
JP2010523471A5 (https=)
JP2010506826A5 (https=)
JP2014534202A5 (https=)
RU2011110376A (ru) Эпитопные пептиды hig2 и urlc10 и содержание их вакцины
RU2011110504A (ru) Эпитопные пептиды inhbb и вакцины, содержащие данные пептиды
JP6786074B2 (ja) エキソソーム標的dnaワクチン
JP2009544614A5 (https=)
JP2011524737A5 (https=)
JP2012517799A5 (https=)
RU2011138160A (ru) Пептиды foxmi и вакцины, содержащие их
JP2015510393A5 (https=)
US20240026317A1 (en) PAN-RAS mRNA CANCER VACCINES
JP2019512020A5 (https=)
JP2013523084A5 (https=)
RU2012127358A (ru) Олигопептиды imp-3 и содержащие их вакцины
JP2016511221A5 (https=)
JP2012520659A5 (https=)
JP2014139185A5 (https=)
JP2012506235A5 (https=)